Online event
Unlocking India's Life Sciences opportunity: Insights for Pharma, MedTech and Diagnostics businesses
Monday 30 November at 2:00PM
Already joined Business Academy? Sign in
Gain practical insights into the UK-India trade agreement and explore the opportunities available in one of the world's most promising life sciences markets.
What you’ll learn
- Understand the evolving India life sciences ecosystem and the commercial opportunities emerging from the UK-India Comprehensive Economic and Trade Agreement..
- Identify key routes to market, regulatory pathways and partnership opportunities across pharma, medtech and diagnostics.
- Learn how the BIST team in India can help accelerate your market entry and business development in India.
Description
India is rapidly emerging as one of the world's most dynamic life sciences markets, underpinned by rising healthcare demand, increasing healthcare expenditure, a thriving innovation ecosystem, and strong government support for advanced manufacturing and R&D.
Referred to as the "Pharmacy of the World", India is the world's largest supplier of generic medicines, accounting for approximately 20% of global generic drug supply, while also producing around 60% of the world's vaccines. India ranks among the top pharmaceutical manufacturing nations globally and exports medicines to more than 200 countries. This combination of scale, innovation, and manufacturing strength makes India a key destination for UK biopharmaceutical SMEs seeking partnership opportunities, market access, and supply chain resilience.
Beyond pharmaceuticals, India is also one of the world's fastest-growing markets for medical technology and diagnostics, driven by increasing healthcare investment, expanding access to care, rising demand for advanced technologies, and a strong focus on disease prevention and early diagnosis. The Indian diagnostics market is already among the largest in Asia, estimated at approximately £30 billion in 2025, and is projected to grow to around £90 billion by 2034, nearly tripling in size within a decade. As healthcare providers and laboratories increasingly adopt innovative medical devices, digital health solutions and diagnostic technologies, India presents a significant export and partnership opportunity for UK medtech and diagnostics SMEs looking to scale internationally.
Join the BIST team for an insightful webinar exploring the commercial opportunities available to UK life sciences businesses and how to successfully navigate this high-growth market. The session will provide an overview of India's life sciences landscape, key market trends, regulatory considerations, and partnership opportunities.
Discover how your business can accelerate growth and establish valuable long-term partnerships in one of the world's most exciting healthcare markets.